secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0000950170-25-083131
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta shareholders approve 4.3M share increase to 2018 equity plan, 0.3M to ESPP
--------------------------------------------------------------------------------

- Vote approves adding 4,300,000 shares to 2018 Equity Incentive Plan (total now 17,487,596).
- Vote approves adding 300,000 shares to 2016 ESPP (total now 1,700,000 shares).
- Re-elected directors Barry, Behrens, Mayo, Nicaise with majority support.
- Advisory vote on 2024 named executive officer compensation passed (72.1M for, 2.2M against).
- Ratified KPMG as independent auditor for FY2025 (80.6M for, 3.9M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000095017025083131/0000950170-25-083131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000095017025083131/srpt-20250605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-083131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer